Pharmaceutical supply chains are not in the business of delivering products. They are responsible for human wellbeing and delivering high-quality care to patients. For that reason, there’s nothing more important than reliability in pharma & healthcare logistics. In the current situation, the flexibility to respond to the reality of the task at hand is also paramount. For instance, a company may meet critical deadlines by flying its Covid-19 vaccine to those hit by another wave of the pandemic. Conversely, for the planned global rollout of billions of doses of the vaccine, the same company may want to ship its product across continents.

The question is, are today’s carriers equipped to transport the most fragile, high-value, regulated cargo in the world?

Re-evaluating the modal mix for pharmaceutical supply chains

The evolution of Ocean logistics for Pharmaceuticals

Transporting high-value cargo over long distances with zero room for error is a complex affair, only to be made more challenging by the multiple audits imposed by Pharma companies and regulators.

Over the years, however, supply chain solution providers have taken a strategic approach to minimise logistics risks on the ocean. At the heart of this approach is a commitment to complete supply chain transparency using integrated digital platforms and visibility tools. With such solutions, logistics service providers are now able to put control back into the hands of Pharma businesses by enabling them to take real-time decisions that prevent issues and minimise the loss of their sensitive cargo.

More recently, the industry has identified the need for new inventory models that shock-proof their businesses. Here too, Ocean solutions play the role of a ‘floating warehouse’, enabling manufacturers to supplement their just-in-time with just-in-case (safety stock) inventory strategies.

But is this enough for Pharma companies to substantially increase Ocean’s share in their modal mix?

Ocean transportation is reliable

Historically, companies have tried to overcome the complexities of running a Pharma supply chain with speed – the faster you take a product from A to B, the fewer errors you’re likely to experience along the way, right? Unfortunately, this isn’t always the case. Pallets are vulnerable to temperature deviations and contamination on the tarmac, especially if there are multiple handoffs and handling of the product.

Refrigerated containers, on the other hand, can take a Pharma product from production to patient with minimal handling, as the door of the container need not be opened at all. Remote container visibility and monitoring help Pharma manufacturers stay ahead of possible issues. And proactive issue handling prevents temperature deviations from resulting in loss of the product. It should come as no surprise then that ocean-related excursions amount to less than 1% of all excursions in one journey.

Ocean logistics can make products accessible to everyone

Today, 30-40% of the cost of a vaccine can be attributed to its transportation. Yet, the need to keep quality, care and service levels high has always put the reduction of logistics costs on the back seat.

Not anymore.

Companies aiming to make the Covid-19 vaccine accessible to middle and low-income families around the world are now looking for ways to keep their vaccine affordable. Ocean transport makes this possible as it is approximately 78% less expensive than Air transport.

Ocean solutions are sustainable

Air transport emits 1,000 gm of CO2 per kg of products per 1,000km. In comparison, Ocean transport emits only 40 gm of CO2 per kg of products per 1,000km. That means increasing the role of Ocean in your modal mix can reduce your carbon footprint by up to 1/25 times per journey, improving brand reputation a great deal.

Making Ocean a viable option for Pharma companies

International Pharma companies approach Maersk because of our extensive network, our 80+ years of experience in refrigerated cargo transportation, and our fleet of 360,000 containers (the largest in the world). They sign up with us because they believe our Reefer excellence team and our end to end portfolio of logistics solutions — including Air Freight, Inland, Warehousing and Distribution, and real-time data solutions — can simplify and connect their supply chains. They remain partners with us because we go all the way to protect the integrity of their products by improving infrastructure at terminals, ensuring faster handovers, planning last-mile flows more efficiently, and providing complete transparency throughout the cold chain.

Don’t take our word for it.

If you’re looking to ship your Pharma products, you can reach out to us to discuss a trial. If our quality approach and operational efficiency meet your needs, we can join hands as partners.

Hristo Petkov
Hristo Petkov
Global Head of Pharma & Healthcare Vertical

无论您需要什么,我们都可以随时为您提供帮助

解决方案

解决方案

我们满足从供应链一端到另一端的客户需求。
联系我们

联系我们

我们的专家团队随时为您服务。
查询价格

准备好运送货物?

查询航运及内陆运输费率。
关注最新动态
注册订阅马士基新闻与洞察
收取直接发送至您收件箱的有关供应链趋势的宝贵信息,在业内保持一路领先

提交此表,即表示我同意通过电子邮件接收 A. P. 穆勒-马士基集团及其关联公司接收物流相关新闻和营销信息更新。我了解我可以随时通过点击退订链接,取消接收此类马士基推送信息。如需查看我们会如何处理您的个人信息,请查阅隐私公告

感谢您注册
您现在已经注册接收新闻通讯。您很快将收到一封电子邮件,其中将说明如何对该新闻通讯进行偏好设置。
已订阅
您可以随时取消订阅。